117 related articles for article (PubMed ID: 11220906)
21. [Helicobacter pylori and gastroesophageal reflux disease: Protective, aggressive or innocent bystander?].
Pellicano R
Minerva Gastroenterol Dietol; 2000 Mar; 46(1):67-70. PubMed ID: 19320080
[No Abstract] [Full Text] [Related]
22. [Helicobacter pylori and gastro-esophageal reflux disease: clinical considerations].
Berrutti M; Fagoonee S; Astegiano M; Pellicano R; Rizzetto M
Minerva Gastroenterol Dietol; 2007 Jun; 53(2):153-6. PubMed ID: 17557043
[TBL] [Abstract][Full Text] [Related]
23. Patience is a virtue in the management of gastroesophageal reflux.
Clark RH; Spitzer AR
J Pediatr; 2009 Oct; 155(4):464-5. PubMed ID: 19772996
[No Abstract] [Full Text] [Related]
24. Treatment of gastroesophageal reflux disease: to step or not to step.
McGuigan JE
Am J Gastroenterol; 2001 Jun; 96(6):1679-81. PubMed ID: 11419813
[No Abstract] [Full Text] [Related]
25. Helicobacter pylori and gastro-oesophageal reflux disease.
Attwood S
Aliment Pharmacol Ther; 1999 Aug; 13(8):1132-4. PubMed ID: 10469472
[No Abstract] [Full Text] [Related]
26. What is the most effective regimen for eradication of Helicobacter pylori in patients who have failed a first eradication attempt?
Markova T; Schwartz K
J Fam Pract; 2002 Jan; 51(1):14. PubMed ID: 11927054
[No Abstract] [Full Text] [Related]
27. Negative effect of ranitidine on the results of urea breath test for the diagnosis of Helicobacter pylori.
Savarino V; Tracci D; Dulbecco P; Mele MR; Zentilin P; Mansi C; Vigneri S
Am J Gastroenterol; 2001 Feb; 96(2):348-52. PubMed ID: 11232674
[TBL] [Abstract][Full Text] [Related]
28. Long-term gastroesophageal reflux disease therapy improves reflux symptoms in elderly patients: five-year prospective study in community medicine.
Miyamoto M; Haruma K; Kuwabara M; Nagano M; Okamoto T; Tanaka M
J Gastroenterol Hepatol; 2007 May; 22(5):639-44. PubMed ID: 17444849
[TBL] [Abstract][Full Text] [Related]
29. [Prevalence of Helicobacter pylori infection among children and youth with acid gastroesophageal reflux].
Brazowski J; Nowak A; Szaflarska-Popławska A
Przegl Lek; 2006; 63(3):128-30. PubMed ID: 16967700
[TBL] [Abstract][Full Text] [Related]
30. Impact of Helicobacter pylori eradication on the anti-secretory efficacy of lansoprazole in gastroesophageal reflux disease patients.
Giral A; Celikel CA; Ozdogan O; Tözün N; Ulusoy NB; Kalayci C
J Gastroenterol Hepatol; 2005 Dec; 20(12):1886-91. PubMed ID: 16336449
[TBL] [Abstract][Full Text] [Related]
31. [Evidence-based medicine on the relationship between Helicobacter pylori and gastroesophageal reflux disease].
Wang JY; Tu CT
Zhonghua Yi Xue Za Zhi; 2006 Oct; 86(38):2667-9. PubMed ID: 17199972
[No Abstract] [Full Text] [Related]
32. Gastro-oesophageal reflux disease and Helicobacter pylori or gastro-oesophageal reflux disease from Helicobacter pylori?
Lundell L
Eur J Gastroenterol Hepatol; 2001 May; 13 Suppl 1():S23-7. PubMed ID: 11430505
[TBL] [Abstract][Full Text] [Related]
33. [Helicobacter eradication in gastritis and ulcers. Causal therapy, prevention of stomach cancer].
MMW Fortschr Med; 2003 Aug; 145(33-34):54-5. PubMed ID: 14526576
[No Abstract] [Full Text] [Related]
34. Therapy with gastric acidity inhibitors increases the risk of acute gastroenteritis and community-acquired pneumonia in children.
Canani RB; Cirillo P; Roggero P; Romano C; Malamisura B; Terrin G; Passariello A; Manguso F; Morelli L; Guarino A;
Pediatrics; 2006 May; 117(5):e817-20. PubMed ID: 16651285
[TBL] [Abstract][Full Text] [Related]
35. Review article: Helicobacter pylori and gastro-oesophageal reflux disease--the European perspective.
McColl KE
Aliment Pharmacol Ther; 2004 Dec; 20 Suppl 8():36-9. PubMed ID: 15575871
[TBL] [Abstract][Full Text] [Related]
36. Helicobacter pylori and GERD.
McColl KE
Am J Gastroenterol; 2005 Jul; 100(7):1620-1; author reply 1621. PubMed ID: 15984991
[No Abstract] [Full Text] [Related]
37. Tolerance to H2 receptor antagonist correlates well with the decline in efficacy against gastroesophageal reflux in patients with gastroesophageal reflux disease.
Furuta K; Adachi K; Komazawa Y; Mihara T; Miki M; Azumi T; Fujisawa T; Katsube T; Kinoshita Y
J Gastroenterol Hepatol; 2006 Oct; 21(10):1581-5. PubMed ID: 16928220
[TBL] [Abstract][Full Text] [Related]
38. An inverse relation between CagA+ strains of Helicobacter pylori infection and risk of erosive GERD.
Somi MH; Fattahi E; Fouladi RF; Karimi M; Bonyadi R; Baballou Z
Saudi Med J; 2008 Mar; 29(3):393-6. PubMed ID: 18327366
[TBL] [Abstract][Full Text] [Related]
39. Helicobacter pylori and gastro-oesophageal reflux disease: important data were not presented.
Beales IL
BMJ; 2004 Aug; 329(7462):402. PubMed ID: 15310619
[No Abstract] [Full Text] [Related]
40. Gastroesophageal reflux and histamine2 antagonists.
Bell SG
Neonatal Netw; 2003; 22(2):53-7. PubMed ID: 12696725
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
